HopeStage
Back to all studies
WithdrawnNCT01725334

Deep Brain Stimulation (DBS) for the Management of Treatment Refractory Negative Symptoms in Schizophrenia

Interventional studyAges 25–60Canada
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 25 years to 60 years. Other eligibility criteria apply.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateSeptember 2012
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Centre for Addiction and Mental Health
Sponsor type
Hospital / academic medical center
Study type
Procedure
Intervention type
Procedure
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
Canada
Age range
From 25 Years to 60 Years
Official registry ID
NCT01725334
Official title
Show the full official title

Deep Brain Stimulation for the Management of Treatment Refractory Negative Symptoms in Schizophrenia

Recruitment & locations

Withdrawn

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 25 years to 60 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies